Contents

Search


lysosomal acid lipase; cholesterol ester hydrolase

Pathology: - deficiency results in lysosomal acid lipase deficiency (cholesterol ester storage disease) Pharmacology: - recombinant lysosomal acid lipase sebelipase alfa (Kanuma) FDA approved to treat lysosomal acid lipase deficiency [1] Laboratory: - lysosomal acid lipase in fibroblasts - lysosomal acid lipase in leukocytes

Specific

lysosomal acid lipase-A (acid cholesterol ester hydrolase, LIPA) lysosomal acid lipase-B (cholesterol ester hydrolase-B) lysosomal acid lipase-C (cholesterol ester hydrolase-C)

General

lipase lysosomal hydrolase

Properties

COMPARTMENT: lysosome MOTIF: active site glycosylation site

Database Correlations

OMIM 278000

References

  1. OMIM :accession 278000
  2. Medscape Oncology. Dec 8, 2015 FDA OKs First Drug (Kanuma) for Rare Enzyme Disease http://www.medscape.com/viewarticle/855617